The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–253 of 253
MAZZIO, E. A., Reams, R., & Soliman, K. F. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.034 · Cited by 107
Liou, H., Chen, R.-C., Tsai, Y.-F., Chen, W., Chang, Y.-C., & Tsai, M.-C. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0054 · Cited by 105
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252965 · Cited by 105
Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice
Nieto, M., Gil-Bea, F. J., Dalfó, E., Cuadrado‐Tejedor, M., Cabodevilla, F., Sánchez, B., Catena, S., Sesma, T., Ribé, E. M., Ferrer, I., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.010 · Cited by 103
Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway
Liou, A. K. F., Leak, R. K., Li, L., & Zigmond, M. J. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.016 · Cited by 99
Hunot, S., Bernard, V., Faucheux, B. A., Boissi�re, F., Leguern, É., Brana, C., Gautris, P. P., rin, J. G., Bloch, B., Agid, Y., et al. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291789 · Cited by 98
Daher, J. P. L., Ying, M., Banerjee, R., McDonald, R. S., Hahn, M. D., Yang, L., Beal, M. F., Thomas, B., Dawson, V. L., Dawson, T. M., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-34 · Cited by 98
Immunological features of α‐synuclein in Parkinson's disease
Roodveldt, C., Christodoulou, J., & Dobson, C. M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00450.x · Cited by 98
Manning-Bog, A., Caudle, W. M., Perez, X. A., Reaney, S. H., Paletzki, R. F., Isla, M. Z., Chou, V., McCormack, A. L., Miller, G. W., Langston, J. W., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.014 · Cited by 96
Chauhan, V. S., Sterka, D. G., Furr, S. R., Young, A. B., & Marriott, I. (2008) · Glia · doi:10.1002/glia.20770 · Cited by 95
Higgins, D. S., & Greenamyre, J. T. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03807.1996 · Cited by 92
Modeling neuroinflammatory pathogenesis of Parkinson’s disease
Barnum, C. J., & Tansey, M. G. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84006-3 · Cited by 91
Rousseaux, M. W. C., Marcogliese, P. C., Qu, D., Hewitt, S. J., Seang, S., Kim, R. H., Slack, R. S., Schlossmacher, M. G., Lagace, D. C., Mak, T. W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205102109 · Cited by 91
Gupta, S. P., Patel, S., Yadav, S., Singh, A. K., Singh, S. K., & Singh, M. P. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0176-5 · Cited by 90
Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease
Chinta, S. J., & Andersen, J. K. (2010) · Free Radical Research · doi:10.3109/10715762.2010.509398 · Cited by 90
Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291792 · Cited by 90
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease
Schintu, N., Frau, L., Ibba, M., Garau, A., Carboni, E., & Carta, A. R. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9061-x · Cited by 89
Zhou, F., Wu, J., Sun, X., Yao, H., Ding, J., & Hu, G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301381 · Cited by 88
Mortality, oxidative stress and tau accumulation during ageing in parkin null mice
Rodríguez‐Navarro, J. A., Casarejos, M. J., Menéndez, J., Solano, R. M., Rodal, I., Gómez, A., de Yébenes, J. G., & Mena, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04762.x · Cited by 88
Oxidative Stress in Genetic Mouse Models of Parkinson’s Disease
Varçin, M., Bentea, E., Michotte, Y. M., & Sarre, S. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/624925 · Cited by 88
Mangano, E. N., Litteljohn, D., So, R., Nelson, E., Peters, S., Bethune, C., Bobyn, J., & Hayley, S. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.016 · Cited by 86
Bian, M., Liu, J., Hong, X., Yu, M., Huang, Y., Sheng, Z., Fei, J., & Huang, F. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039953 · Cited by 85
Haque, M. E., Mount, M. P., Safarpour, F., Abdel-Messih, E., Callaghan, S., Mazerolle, C., Kitada, T., Slack, R. S., Wallace, V., Shen, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.346437 · Cited by 84 · cited 1×
“Pink1 knockout mice are more susceptible to DA degeneration and striatal DA depletion induced by MPTP, but significantly, this can be rescued by the viral mediated expression of parkin or DJ-1 (Haque et al., 2012).”
BackgroundParkinson’s disease mouse models in translational research
Antony, P. M. A., Diederich, N. J., & Balling, R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9330-x · Cited by 84
Analysis of an early‐onset Parkinson's disease cohort for DJ‐1 mutations
Clark, L. N., Afridi, S. K., Mejia‐Santana, H., Harris, J. M., Louis, E. D., COTE, L. J., Andrews, H., Singleton, A., DeVriéze, F. W., Hardy, J., et al. (2004) · Movement Disorders · doi:10.1002/mds.20131 · Cited by 80
Kalkonde, Y. V., MORGAN, W. W., Sigala, J. A., Maffi, S. K., Condello, C., Kuziel, W. A., Ahuja, S. S., & Ahuja, S. K. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.041 · Cited by 75
Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice
Yamaguchi, H., & Shen, J. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-10 · Cited by 75
Pattarini, R., Smeyne, R. J., & Morgan, J. I. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.030 · Cited by 73
Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation
Lee, K.-W., Zhao, X., Im, J., Grosso, H., Jang, W. H., Chan, T. W., Sonsalla, P. K., German, D. C., Ichijo, H., Junn, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029935 · Cited by 71
Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
Riachi, N. J., LaManna, J. C., & Harik, S. I. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23492-9 · Cited by 70
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
Perez, F. A., Curtis, W., & Palmiter, R. D. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-71 · Cited by 68
Ciesielska, A., Joniec‐Maciejak, I., Przybyłkowski, A. M., Gromadzka, G., Iwona, Członkowska, A., & Członkowski, A. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1461 · Cited by 68
Autotoxicity, methylation and a road to the prevention of Parkinson’s disease
Williams, A. C., & Ramsden, D. B. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.10.002 · Cited by 65
Carta, A. R., Kachroo, A., Schintu, N., Xu, K., Schwarzschild, M. A., Wardas, J., & Morelli, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06425.x · Cited by 64
Ferraro, T. N., Golden, G. T., DeMattei, M., Hare, T. A., & Fariello, R. G. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90205-4 · Cited by 61
Li, X., Moore, D. J., Xiong, Y., Dawson, T. M., & Dawson, V. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127639 · Cited by 60
Cunningham, C. M., Wilcockson, D. C., Boche, D., & Perry, V. H. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5174-5184.2005 · Cited by 55
Mogi, M., Togari, A., Tanaka, K.-I., et al. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01275-1 · Cited by 53
Iravani, M. M., Sadeghian, M., Leung, C. C. M., Jenner, P. G., & Rose, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.01.022 · Cited by 53
Parkinson's disease and aging: Same or different process?
Hawkes, C. H. (2007) · Movement Disorders · doi:10.1002/mds.21766 · Cited by 49
Dong, Z., Ferger, B., Feldon, J., & Büeler, H. (2002) · Journal of Neurobiology · doi:10.1002/neu.10094 · Cited by 49
Hyun, D., Lee, M., Halliwell, B. B., & Jenner, P. G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20638 · Cited by 47
Drolet, R. E., Sanders, J. M., & Kern, J. T. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.627072 · Cited by 47
Diedrich, M., Kitada, T., Nebrich, G., Koppelstaetter, A., Shen, J., Zabel, C., Klose, J., & Mao, L. (2011) · Proteome Science · doi:10.1186/1477-5956-9-59 · Cited by 47
Yue, Z., & Lachenmayer, M. L. (2011) · Movement Disorders · doi:10.1002/mds.23737 · Cited by 41
George, S., Mok, S. S., Nurjono, M., Ayton, S., Finkelstein, D. I., Masters, C. L., Li, Q., & Culvenor, J. G. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9378-1 · Cited by 40
Yasuda, Y. U., Shinagawa, R., Yamada, M., Mori, T. A., Tateishi, N., & Fujita, S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.054 · Cited by 35
Kunikowska, G., & Jenner, P. G. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03149-3 · Cited by 35
The impact of genetic research on our understanding of Parkinson’s disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83002-x · Cited by 32
Parkinson’s disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans
Castro, E. M. C., Waak, J., Weber, S. S., Fiesel, F. C., Oberhettinger, P., Schütz, M. S., Autenrieth, I. B., Springer, W., & Kahle, P. J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0397-4 · Cited by 32
Pesticide exposure might be a strong risk factor for Parkinson's disease
Baldereschi, M., Inzitari, M., Vanni, P., Carlo, A. D., & Inzitari, D. (2007) · Annals of Neurology · doi:10.1002/ana.21049 · Cited by 20
Zhou, H., Huang, C., Tong, J., & Xia, X. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1180 · Cited by 19
Shimura, H., Mizuno, Y., & Hattori, N. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.187054 · Cited by 7
Cited by
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
Nabavi, S. F., Braidy, N., Gortzi, O., Sobarzo-Sanchez, E., Daglia, M., Skalicka-Woźniak, K., & Nabavi, S. M. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.09.002 · Cited by 480
Tamtaji, O. R., Taghizadeh, M., Daneshvar Kakhaki, R., Kouchaki, E., Bahmani, F., Borzabadi, S., Oryan, S., Mafi, A., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.018 · Cited by 398
Retracted
Metadata
- Authors
- Taylor, J. M., Main, B. S., & Crack, P. J.
- Venue
- Neurochemistry International
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 62
- Issue
- 5
- Pages
- 803-819
- ISSN
- 0197-0186 (ISSN-L)
- OpenAlex
- W2073777605
- Cited by
- 303
- References
- 253
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.